These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1307299)

  • 21. [Adrenal vein catheterization in primary hyperaldosteronism: aid in surgical decision making?].
    Nascimbeni L; Lyonnet D; Vincent M; Lantelme P; Gouton M; Froment A; Ecochard R; Claustrat B; Milon H
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):874-8. PubMed ID: 11575222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
    Herpin D; Sosner P; Amar J; Chamontin B
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
    Vierhapper H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):518-21. PubMed ID: 17853335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary aldosteronism.
    Biglieri EG
    Curr Ther Endocrinol Metab; 1994; 5():152-5. PubMed ID: 7704703
    [No Abstract]   [Full Text] [Related]  

  • 28. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal and salivary electrolytes in the diagnosis of primary aldosteronism.
    Wilson DR; Laidlaw JC; Ruse JL
    Can Med Assoc J; 1971 Dec; 105(12):1300-5. PubMed ID: 5150332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of aldosterone-producing adenoma associated with end-stage renal disease].
    Kojima Y; Miyake O; Morimoto A; Kawamura C; Katayama S
    Hinyokika Kiyo; 2010 Jan; 56(1):21-4. PubMed ID: 20104005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
    Hood S; Cannon J; Foo R; Brown M
    Clin Med (Lond); 2005; 5(1):55-60. PubMed ID: 15745200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone-renin ratio in the assessment of primary aldosteronism.
    Kumar B; Swee M
    JAMA; 2014 Jul; 312(2):184-5. PubMed ID: 25005657
    [No Abstract]   [Full Text] [Related]  

  • 35. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.
    Sindelka G; Widimský J; Haas T; Prázný M; Hilgertová J; Skrha J
    Exp Clin Endocrinol Diabetes; 2000; 108(1):21-5. PubMed ID: 10768828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis, localization, and treatment of primary aldosteronism.
    Weinberger MH; Grim CE; Higgins JT
    Compr Ther; 1977 May; 3(5):12-7. PubMed ID: 862382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.